complement 3a

TLQP 21 acetate is a potent agonist of G-protein-coupled receptor complement-3a receptor 1 (C3aR1). The EC50 values are 10.3 μM for mouse and 68.8 μM for human. TLQP 21 acetate is a VGF-derived peptide with endocrine and extraendocrine properties.

C3a 70-77 2TFA(63555-63-5(free base)) (Complement 3a (70-77)) is an octapeptide corresponding to the COOH terminus of C3a.

TLQP-21 TFA, a VGF-derived peptide with endocrine and extraendocrine properties, acts as a potent G-protein-coupled receptor complement-3a receptor1 (C3aR1) agonist (EC50: mouse TLQP-21=10.3 μM; human TLQP-21=68.8 μM), activating C3aR1 to increase intracellular Ca2+ levels, and is used in research on nociception regulation and other relevant physiological functions[1][2].

C3a (70-77) is an octapeptide that corresponds to the COOH terminus of C3a.

Complement 3a (70-77) TFA is an octapeptide that corresponds to the COOH terminus of C3a and exhibits the specificity and 1 to 2% biological activities of C3a [1] [2].

C3a (70-77) TFA (Complement 3a (70-77) TFA) is a COOH-terminal fragment of the C3a anaphylatoxin peptide.